dextroamphetamine has been researched along with Addiction, Opioid in 10 studies
Dextroamphetamine: The d-form of AMPHETAMINE. It is a central nervous system stimulant and a sympathomimetic. It has also been used in the treatment of narcolepsy and of attention deficit disorders and hyperactivity in children. Dextroamphetamine has multiple mechanisms of action including blocking uptake of adrenergics and dopamine, stimulating release of monamines, and inhibiting monoamine oxidase. It is also a drug of abuse and a psychotomimetic.
(S)-amphetamine : A 1-phenylpropan-2-amine that has S configuration.
| Excerpt | Relevance | Reference |
|---|---|---|
| "While all have the goal of treating pain while mitigating misuse and abuse, there are different technologies utilized to impart the abuse-deterrent properties." | 2.48 | Abuse-deterrent formulations, an evolving technology against the abuse and misuse of opioid analgesics. ( Schaeffer, T, 2012) |
| " dosing and dispensation protocols) can be adjusted to allow for various scenarios (e." | 1.62 | Exploring the effectiveness of dextroamphetamine for the treatment of stimulant use disorder: a qualitative study with patients receiving injectable opioid agonist treatment. ( Bojanczyk-Shibata, A; Harrison, S; Jun, J; Lock, K; MacDonald, S; Marchand, K; Marsh, DC; Oviedo-Joekes, E; Palis, H; Peachey, GS; Schechter, MT; Westfall, J, 2021) |
| "Dextroamphetamine was prescribed to a 51-year-old male who was diagnosed with concurrent opioid and stimulant use disorder in an injectable opioid agonist treatment clinic in Vancouver, Canada." | 1.62 | Use of sustained release dextroamphetamine for the treatment of stimulant use disorder in the setting of injectable opioid agonist treatment in Canada: a case report. ( Jun, J; MacDonald, S; Oviedo-Joekes, E; Palis, H, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (10.00) | 18.7374 |
| 1990's | 2 (20.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (30.00) | 24.3611 |
| 2020's | 4 (40.00) | 2.80 |
| Authors | Studies |
|---|---|
| Palis, H | 2 |
| Marchand, K | 1 |
| Peachey, GS | 1 |
| Westfall, J | 1 |
| Lock, K | 1 |
| MacDonald, S | 2 |
| Jun, J | 2 |
| Bojanczyk-Shibata, A | 1 |
| Harrison, S | 1 |
| Marsh, DC | 1 |
| Schechter, MT | 1 |
| Oviedo-Joekes, E | 2 |
| Blanken, P | 1 |
| Nuijten, M | 1 |
| van den Brink, W | 1 |
| Hendriks, VM | 1 |
| Vohra, V | 1 |
| King, A | 1 |
| Daviskiba, S | 1 |
| Reed, B | 1 |
| Rockhill, S | 1 |
| Kern, P | 1 |
| Dean, D | 1 |
| Jordan, CJ | 1 |
| Cao, J | 1 |
| Newman, AH | 1 |
| Xi, ZX | 1 |
| Greenwald, MK | 1 |
| Lundahl, LH | 1 |
| Steinmiller, CL | 1 |
| Schaeffer, T | 1 |
| Charnaud, B | 1 |
| Griffiths, V | 1 |
| Higgins, ST | 1 |
| Preston, KL | 1 |
| Cone, EJ | 1 |
| Henningfield, JE | 2 |
| Jaffe, JH | 1 |
| Lamb, RJ | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Efficacy and Safety of 24 Weeks Sustained-release Dexamphetamine in Patients With Moderate to Severe Cocaine Use Disorder With Comorbid Opioid Use Disorder - A Multicenter Randomized, Double-blind, Placebo-controlled Study[NCT05529927] | Phase 2 | 204 participants (Anticipated) | Interventional | 2024-03-31 | Not yet recruiting | ||
| Reducing Cocaine/Heroin Abuse With SR-Amphetamine and Buprenorphine: Study 1[NCT00429767] | 16 participants (Anticipated) | Observational | 2007-01-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for dextroamphetamine and Addiction, Opioid
| Article | Year |
|---|---|
Progress in agonist therapy for substance use disorders: Lessons learned from methadone and buprenorphine.
Topics: Analgesics, Opioid; Buprenorphine; Central Nervous System Stimulants; Cocaine-Related Disorders; Dex | 2019 |
Abuse-deterrent formulations, an evolving technology against the abuse and misuse of opioid analgesics.
Topics: Analgesics, Opioid; Buprenorphine; Chemistry, Pharmaceutical; Dextroamphetamine; Humans; Lisdexamfet | 2012 |
3 trials available for dextroamphetamine and Addiction, Opioid
| Article | Year |
|---|---|
Clinical effects beyond cocaine use of sustained-release dexamphetamine for the treatment of cocaine dependent patients with comorbid opioid dependence: secondary analysis of a double-blind, placebo-controlled randomized trial.
Topics: Adult; Central Nervous System Stimulants; Cocaine-Related Disorders; Delayed-Action Preparations; De | 2020 |
Sustained release d-amphetamine reduces cocaine but not 'speedball'-seeking in buprenorphine-maintained volunteers: a test of dual-agonist pharmacotherapy for cocaine/heroin polydrug abusers.
Topics: Adolescent; Adult; Buprenorphine; Choice Behavior; Cocaine; Cocaine-Related Disorders; Delayed-Actio | 2010 |
Supersensitivity to naloxone following acute morphine pretreatment in humans: behavioral, hormonal and physiological effects.
Topics: Adult; Arousal; Blood Pressure; Body Temperature Regulation; Dextroamphetamine; Dose-Response Relati | 1992 |
5 other studies available for dextroamphetamine and Addiction, Opioid
| Article | Year |
|---|---|
Exploring the effectiveness of dextroamphetamine for the treatment of stimulant use disorder: a qualitative study with patients receiving injectable opioid agonist treatment.
Topics: Analgesics, Opioid; Central Nervous System Stimulants; Dextroamphetamine; Humans; Methamphetamine; O | 2021 |
Stimulant storm - state health department psychostimulant age-adjusted mortality rate correlates with psychostimulant-based Michigan Poison Center case exposures over time.
Topics: Adult; Amphetamine; Central Nervous System Stimulants; Dextroamphetamine; Drug Overdose; Female; Hum | 2021 |
Use of sustained release dextroamphetamine for the treatment of stimulant use disorder in the setting of injectable opioid agonist treatment in Canada: a case report.
Topics: Analgesics, Opioid; Canada; Central Nervous System Stimulants; Delayed-Action Preparations; Dextroam | 2021 |
Levels of intravenous drug misuse among clients prescribed oral dexamphetamine or oral methadone: a comparison.
Topics: Adult; Dextroamphetamine; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Female; Huma | 1998 |
Human d-amphetamine drug discrimination: testing with d-amphetamine and hydromorphone.
Topics: Adult; Arousal; Dextroamphetamine; Discrimination Learning; Dose-Response Relationship, Drug; Humans | 1989 |